- Home
- SNDA vs CMRX Comparison
SNDA vs CMRX Comparison
Compare SNDA & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDA
- CMRX
- Stock Information
- Founded
- SNDA 1990
- CMRX 2000
- Country
- SNDA United States
- CMRX United States
- Employees
- SNDA N/A
- CMRX N/A
- Industry
- SNDA Hospital/Nursing Management
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- SNDA Health Care
- CMRX Health Care
- Exchange
- SNDA Nasdaq
- CMRX Nasdaq
- Market Cap
- SNDA 462.3M
- CMRX 394.1M
- IPO Year
- SNDA 1997
- CMRX 2013
- Fundamental
- Price
- SNDA $25.11
- CMRX $5.15
- Analyst Decision
- SNDA Hold
- CMRX Strong Buy
- Analyst Count
- SNDA 1
- CMRX 2
- Target Price
- SNDA $25.00
- CMRX $8.50
- AVG Volume (30 Days)
- SNDA 27.0K
- CMRX 1.7M
- Earning Date
- SNDA 03-26-2025
- CMRX 02-27-2025
- Dividend Yield
- SNDA N/A
- CMRX N/A
- EPS Growth
- SNDA N/A
- CMRX N/A
- EPS
- SNDA N/A
- CMRX N/A
- Revenue
- SNDA $253,196,000.00
- CMRX $159,000.00
- Revenue This Year
- SNDA $14.30
- CMRX N/A
- Revenue Next Year
- SNDA $9.72
- CMRX $1,690.28
- P/E Ratio
- SNDA N/A
- CMRX N/A
- Revenue Growth
- SNDA 10.95
- CMRX N/A
- 52 Week Low
- SNDA $10.99
- CMRX $0.75
- 52 Week High
- SNDA $34.26
- CMRX $5.53
- Technical
- Relative Strength Index (RSI)
- SNDA 56.72
- CMRX 76.25
- Support Level
- SNDA $24.99
- CMRX $3.94
- Resistance Level
- SNDA $26.46
- CMRX $5.53
- Average True Range (ATR)
- SNDA 0.93
- CMRX 0.30
- MACD
- SNDA 0.10
- CMRX 0.07
- Stochastic Oscillator
- SNDA 67.94
- CMRX 78.29
About SNDA Sonida Senior Living Inc.
Sonida Senior Living Inc is an owner-operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.